CARPL.ai raises $10 million in Series A funding led by IFC

In July 2026, CARPL.ai, a radiology AI marketplace and enterprise platform, raised USD 10 million in a Series A funding round led by the International Finance Corporation (IFC), the private sector arm of the World Bank Group, with participation from Stellaris Venture Partners and other investors. The company said the funding will support its efforts to help healthcare providers adopt artificial intelligence (AI) across clinical workflows. According to the company, CARPL.ai is used by healthcare organizations, including four of the world’s top five private radiology groups, and by governments in Brazil, India, Singapore, Spain, and the UAE.

The company stated that medical imaging generates more than 80 per cent of healthcare data, while imaging demand continues to outpace radiologist capacity. It noted that although more than 1,000 US Food and Drug Administration (FDA)-cleared radiology AI applications are available, adoption remains fragmented as healthcare organizations are required to evaluate, integrate, and monitor multiple standalone AI products independently. According to the company, this creates operational and IT complexity due to the absence of a unified governance framework.

Through a single integration, CARPL.ai can now provide healthcare providers with access to more than 300 AI applications from over 100 partners through its radiology AI marketplace. The platform also enables customers to build, test, deploy, and monitor AI across clinical workflows while remaining vendor-neutral and infrastructure-agnostic.

According to the company, the investment will support product development, expansion of its global partner ecosystem, and commercial growth across North America, Latin America, Europe, Asia-Pacific, and emerging markets. The company added that the partnership also focuses on developing engineering, product development, and AI capabilities in India for deployment across healthcare providers globally. The company also said that while it currently operates in radiology, it plans to expand beyond medical imaging into pathology, genomics, and general medicine.

Impact on the Healthcare Market

AI aims to tackle major healthcare challenges such as the rising need for complex care, increasing chronic illnesses, a shortage of healthcare workers, and the growth of data and technological tools. By integrating AI into clinical workflows, patient outcomes can be improved through early disease detection and faster drug discovery. AI's ability to analyze intricate datasets enables the identification of subtle disease signs, facilitating timely interventions.

Moreover, AI-driven methods can speed up the creation of new treatments, getting them to patients faster. As AI advances, its potential in healthcare, including predictive analytics and personalized medicine, continues to expand, highlighting its transformative power. Successful adoption will require ongoing collaboration among technology developers, healthcare providers, and policymakers.

Impact on the Radiology AI Market

The global radiology AI market size was USD 794.12 million in 2025 and is projected to increase from USD 989.55 million in 2026 to approximately USD 7,168.28 million by 2035, expanding at a CAGR of 24.61% from 2026 to 2035.

According to Precedence Research, the market for radiology AI is experiencing unprecedented growth, driven by the increasing demand for early detection of chronic diseases. Integration with PACS, EMR systems, and real-time analytics platforms has further enhanced adoption, allowing hospitals and imaging centers to incorporate AI into daily clinical workflows. These technological changes create a strong foundation for scalable, high-quality radiology services across global healthcare systems.

As AI technology continues to evolve, radiologists, researchers, and technologists are continuously innovating to improve patient outcomes. According to the American College of Radiology, 30 percent of radiologists use AI in their clinical practices. Radiology AI uses artificial intelligence algorithms, including deep learning and machine learning (ML), to detect and characterize abnormalities in medical images, such as MRIs, X-rays, mammograms, and CT scans, which assist in timely diagnostics and the planning of personalized treatment strategies.

Impact on the Teleradiology Software Market

The global teleradiology software market size was valued at USD 6.13 billion in 2025 and is anticipated to reach around USD 13.86 billion by 2035, expanding at a CAGR of 8.50% over the forecast period from 2025 to 2035.

According to Precedence Research, the market thrives on the convergence of medical imaging technology and digital communication systems, enabling healthcare professionals to access and analyze medical images from remote locations. Rapid advancements in telecommunications, medical imaging, and data security have propelled the growth of this market, fostered efficient healthcare delivery, and improved diagnostic accuracy.

Despite its growth prospects, the teleradiology software market faces challenges such as data security and privacy concerns, regulatory complexities across regions, and potential limitations in rural areas with limited internet connectivity. However, it presents substantial business opportunities for software developers, healthcare institutions, and radiologists, as the demand for reliable, fast, and accessible radiology services continues to rise. Collaboration with AI developers to improve image analysis accuracy and exploring emerging markets with underserved healthcare infrastructure are among the avenues for growth in this dynamic industry. The teleradiology software market is projected to play an increasingly pivotal role in modern healthcare, ensuring efficient diagnosis and treatment, especially in remote or underserved areas.

Expert Opinion

Farid Fezoua, Global Director for Private Equity and Venture Capital, International Finance Corporation, said,

“Expanding access to high-quality diagnostics in emerging markets is one of the most pressing priorities in global healthcare, and AI is becoming a critical part of the solution. CARPL.ai is building the digital infrastructure that enables healthcare providers to adopt AI at scale, improving diagnostic quality and expanding access to care. IFC is proud to support a company that combines world-class innovation with India’s deep technology talent, creating high-skilled jobs while addressing a critical global healthcare need. This investment reflects the World Bank Group’s commitment to advancing innovation, strengthening digital health ecosystems, and ensuring the benefits of AI reach patients in emerging markets and underserved communities worldwide.”

Alok Goyal, Partner, Stellaris Venture Partners, said,

“We are excited to see CARPL’s remarkable journey since our initial investment and to watch our original thesis play out so strongly. Over the past few years, the team has executed exceptionally well, earning the trust of leading healthcare institutions worldwide, building deep partnerships with leading PACS providers, and enabling millions of patient scans through its platform. This is a testament to the vision, ambition, and execution of Dr. Vidur Mahajan and his team, and we’re excited to continue supporting CARPL as it builds the foundational infrastructure for AI-powered healthcare globally.”